Clinical Trial Update: Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% [Phase 1]

View source ↗

Summary

Phase 1 study evaluating ophthalmic timolol maleate 0.5% for ischemic optic neuropathy has been withdrawn. The reported conditions include ischemic optic neurop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Ischemic Optic Neuropathy
• Ischemic Optic Neuropathy

Drugs mentioned

• Timolol maleate ophthalmic solution 0.5% (timolol maleate ophthalmic solution 0.5%)

Snippet

Sponsor: Fraser Health | Conditions: Optic Neuropathy, Ischemic, Anterior Ischemic Optic Neuropathy | Phase 1 | Status: WITHDRAWN